Captor Capital Corp. (CSE:CPTR)
Canada
· Delayed Price · Currency is CAD 0.265
-0.025 (-8.62%)
Jan 19, 2026, 9:04 AM EST
Captor Capital Revenue
Captor Capital had revenue of 87.97K CAD in the quarter ending December 31, 2025, with 193.83% growth. This brings the company's revenue in the last twelve months to -32.22M, down -185.52% year-over-year. In the fiscal year ending March 31, 2025, Captor Capital had annual revenue of -1.74M, down -105.22%.
Revenue (ttm)
-32.22M
Revenue Growth
-185.52%
P/S Ratio
-0.72
Revenue / Employee
-14.35K
Employees
78
Market Cap
801.99K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | -1.74M | -35.14M | -105.22% |
| Mar 31, 2024 | 33.40M | -8.44M | -20.18% |
| Mar 31, 2023 | 41.84M | 9.10M | 27.80% |
| Mar 31, 2022 | 32.74M | 16.52M | 101.87% |
| Mar 31, 2021 | 16.22M | 3.72M | 29.79% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aequus Pharmaceuticals | 918.47K |
| Vencanna Ventures | 3.60M |
| Adastra Holdings | 16.86M |
| Genix Pharmaceuticals | 68.00 |
| Optimind Pharma | 131.48K |
| Ovation Science | 63.82K |